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Background: Exogenous surfaetant herapy of lung donors improves the 
preservation of normal canine grafts. The current study was designed to 
determine whether exogenous urfactant can mitigate the damage in lung 
grafts induced by mechanical ventilation before procurement. Methods and 
results: Five donor dogs were subjected to 8 hours of mechanical ventilation 
(tidal volume 45 ml/kg). This produced a significant decrease in oxygen 
tension (p = 0.007) and significant increases in bronchoscopic lavage fluid 
neutrophil  count (p = 0.05), protein concentration (p = 0.002), and the 
ratio of poorly functioning small surfactant aggregates to superiorly 
functioning large aggregates (p = 0.02). Five other animals given instil led 
bovine lipid extract surfactant and undergoing mechanical ventilation in 
the same manner demonstrated no significant change in oxygen tension 
values, lavage fluid protein concentration, or the ratio of small to large 
aggregates. All 10 lung grafts were then stored for 17 hours at 4 ° C. Left 
lungs were transplanted and reperfused for 6 hours. After 6 hours of 
reperfusion the ratio of oxygen tension to inspired oxygen fraction was 
307 - 63 mm Hg in lung grafts administered surfactant versus 73 - 14 mm 
Hg in untreated grafts (p = 0.007). Furthermore, peak inspired pressure 
was significantly (p < 0.05) lower in treated animals from 90 to 360 minutes 
of reperfusion. Analysis of lavage fluid of transplanted grafts after reper- 
fusion revealed small to large aggregate ratios of 0.17 - 0.04 and 0.77 - 
0.17 in treated versus untreated grafts, respectively (p = 0.009). Conclu- 
sions: Insti l lation of surfactant before mechanical ventilation reduced 
protein leak, maintained a low surfactant small to large aggregate ratio, 
and prevented a decrease of oxygen tension in donor animals. After 
transplantation, surfactant-treated grafts had superior oxygen tension 
values and a higher proportion of superiorly functioning surfactant aggre- 
gate forms in the air space than untreated grafts. Exogenous surfactant 
therapy can protect lung grafts from ventilation-induced injury and may 
offer a promising means to expand the donor pool. (J Thorac Cardiovasc 
Surg 1997;113:342-53) 
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T he practice of lung transplantation remains con- strained by a severe shortage of suitable donor 
organs] Although lung graft ischemic times of more 
than 6 hours are now commonplace clinically, recent 
registry reports have confirmed that the number of 
lung transplantation procedures done worldwide has 
reached a plateau since 1993. 2This may be, in part, 
due to the fact that more than 75% of multiorgan 
donors have lungs that are not suitable for trans- 
plantation because of edema, aspiration, infection, 
ventilator-induced lung injury, or pulmonary contu- 
sion)' 4 Although the successful outcome of lung 
transplantation is not compromised if donor lungs 
with mild hypoxemia, chronic tobacco exposure, or a 
minor contusion or infiltrate are used, 5use of these 
lungs has not yet had a significant impact on the donor 
organ shortage. New strategies to improve the preser- 
vation of lung grafts from a wider population of donors 
are required to expand the donor pool. 
Recent laboratory work demonstrated that reper- 
fusion of lungs after a prolonged interval of isch- 
emia results in significant endothelial cell damage 
and dysfunction of the alveolar type II cells that 
produce pulmonary surfactant. 1 Previous studies 
have documented that endogenous surfactant was 
altered after transplantation a d that the changes in 
surfactant composition and function in the isch- 
emia-reperfusion injury induced by lung transplan- 
tation in dogs 6 and rats 7 resembled those observed 
in patients with the acute respiratory distress syn- 
drome. 8 Furthermore, work in our laboratory 
showed improved pulmonary function after 36 hours 
of preservation of normal canine lung grafts with the 
use of bovine lipid extract surfactant (bLES) ther- 
apy, as long as the bLES was administered to lung 
donors before the ischemic interval. 9 
Previous tudies have shown that mechanical ven- 
tilation can result in an acute lung injury that is 
characterized by neutrophi! infiltration, increased 
pulmonary vascular permeability, and hyaline mem- 
brane formation. 1° Studies in several animal species 
have demonstrated that ventilation with high tidal 
volumes can rapidly cause this ventilation-induced 
injury. 11-14 Recent work also showed that ventilation 
of normal ungs with tidal volumes of 13 to 15 ml/kg 
resulted in alterations of the alveolar surfactant 
system; specifically, the ratio of poorly functioning 
small surfactant aggregate forms (SA) to the supe- 
riorly functioning large surfactant aggregate forms 
(LA) was increased, is In the clinical setting, many 
potential lung donors receive mechanical ventilation 
for prolonged intervals before brain stem death is 
declared. This period of ventilation may contribute 
to significant pulmonary dysfunction and endoge- 
nous surfactant abnormalities in these patients. 1 We 
have used this model of lung injury for the current 
studies to investigate further the role of exogenous 
surfactant therapy in lung transplantation, particu- 
larly with respect o donor lung preservation. 
The objective of this study, therefore, was to 
determine whether exogenous urfactant adminis- 
tration can mitigate the lung injury induced by 
mechanical ventilation in canine lung grafts before 
procurement. We hypothesized that early adminis- 
tration of exogenous bLES to lung donors would 
decrease the pulmonary damage associated with 
mechanical ventilation and would therefore nable 
these "injured" grafts to exhibit satisfactory function 
after a prolonged interval of hypothermic storage 
and transplantation. 
Material and methods 
Animal preparation. Left single-lung transplantation 
was done in 10 pairs of conditioned, 20 to 25 kg mongrel 
dogs, as previously described. 6'9 Donor and recipient 
animals were premedicated with xylazine, 1 mg/kg, and 
atropine, 0.4 mg/kg, both administered intramuscularly. 
Anesthesia was induced with thiopental sodium, 12 mg/kg 
intravenously, and maintained with 1% halothane by 
inhalation. Animals were intubated with a cuffed endotra- 
cheal tube and volume-cycled mechanical ventilation was 
begun. Neuromuscular blockade was achieved with intra- 
venous pancuronium, 0.1 mg/kg, which was repeated at 
necessary intervals to eliminate spontaneous breathing. 
All animals received humane care in keeping with the 
"Principle s of Laboratory Animal Care" (National Society 
for Medical Research), the "Guide for the Care and Use 
of Laboratory Animals" (National Institutes of Health 
Publication No. 86-23, revised 1985), and the Specifica- 
tions of the Council On Animal Care of the University of 
Western Ontario. 
Donor operation. Before the commencement Of high- 
volume ventilation in donor lungs, an Olympus flexible 
fiberoptic bronchoscope was inserted through a side port 
of the endotracheal tube and wa s wedged into a segmental 
bronchus in the right lower lobe. Thirty milliliters of 
warmed (37 ° C) 0.9% NaC1 was infused through the 
instrument channel of the bronchoscope and immediately 
aspirated with a syringe with the use of gentle suction. 
Approximately 4 ml of lavage fluid was then added to a 
tube containing 0.05 ml of 15% ethylenediaminetetraace- 
tic acid and a cell count of the lavage fluid was done with 
a Coulter STKR hematologic analyzer (Coulter Inc., 
Hialeah, Fla.). Additional lavage specimens were submit- 
ted for the analysis of total protein and surfactant SA and 
LA forms, as described later in this section. 
All donor animals then received mechanical ventilation 
for 8 hours with use of the following settings: fraction of 
inspired oxygen (Fio2) 1.0, positive end-expiratory pres- 
sure 5 cm H20, tidal volume 45 ml/kg, and rate 16 
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breaths/min. Although tidal volumes of 45 ml/kg are not 
used clinically, we chose this volume for our studies to 
produce an experimental lung injury during this period of 
ventilation. During high-volume ventilation, the values of 
peak inspired pressure were recorded every 30 minutes 
and arterial blOod gas values were measured on a Ciba 
Corning 238 blood gas analyzer (Ciba Corning Diagnostic 
Limited, Richmond Hill, Ontario) at the same intervals. 
After 8 hours, the bronchoscope was reintroduced into a 
bronchopulmonary segment in the right lower lobe that 
was different from the segment subjected to lavage previ- 
ously. The lavage procedure was repeated and samples of 
lavage effluent were analyzed for cell count, total protein, 
and surfactant SA and LA. 
A median sternotomy and anterior pericardiectomy 
were then performed. The superior and inferior venue 
cavae, ascending aorta, pulmonary artery (PA), and tra- 
chea were mobilized. Heparin sodium, 300 units/kg, was 
administered, followed several minutes later by an injec- 
tion of prostaglandin E 1 (Upjohn Company, Don Mills, 
Ontario), 250 /xg, into the PA. The donor animals then 
underwent PA flushing with 60 ml/kg of 4°C modified 
Euro-Collins olution. The heart was excised, followed by 
the double-lung block. The double-lung block was manu- 
ally inflated to total lung capacity with 100% 0 2 and was 
stored for 16 to 17 hours immersed in a 4 ° C circulating 
saline solution bath. 
Recipient operation. Sixteen hours after the donor 
operation, weight-matched recipient dogs underwent a 
left posterolateral thoracotomy through the fifth intercos- 
tal space. The right PA was encircled with a heavy silk tie 
for subsequent snaring to obtain blood gas measurements 
of the isolated left lung. 6' 9 In addition, ultrasonic flow 
probes (Transonic Inc., Ithaca, N.Y,) were placed around 
both the left and right PA so that individual PA blood flow 
rates could be continuously monitored throughout he 
operation. The chest was closed with towel clips, and a 
small opening was left through which the right PA snare 
could be manipulated. The animals were placed in a 
supine position and baseline arterial blood gas values 
were measured. Isolated left lung blood gas measure- 
ments were then obtained, the chest Was reopened, and a 
left pneumonectomy was performed. The left atrial cuff, 
PA, and bronchus of the donor left lung were then 
anastomosed to those of the recipient, as previously 
described.6, 9 The left lung graft was fully reinflated and 
the left PA clamp was removed, initiating reperfusion. 
The chest was closed with towel clips, the animal was 
placed in the supine position, and baseline postreperfu- 
sion values of arterial blood gases, Peak inspired pressure, 
and individual PA blood flow rates were recorded. 
Throughout reperfusion, all animals received mechanical 
ventilation with an Fio 2 of 1.0, positive end-expiratory 
pressUre of 5 cm H20, rate of 16 breaths/min, and a tidal 
volume of 20 ml/kg. The ratio of oxygen tension (Poa) to 
Fio2, the carbon dioxide tension (Pc02), the peak inspired 
pressure, and the individual PA blood flow rates were 
recorded at 30-minute intervals during 6 hours of reper- 
fusion. At the end of reperfusion, the right PA snare was 
applied for 10 minutes, enabling measurements of blood 
gas values to be obtained uring isolated perfusion of the 
left lung graft. The animals were then killed with an 
overdose of sodium pentobarbital. The heart was vented 
by incising the left atrial appendage, descending aorta, 
and main PA and the trachea was clamped at end 
inspiration. The double-lung block was removed and 
individual whole lung lavage procedures were done as 
described later in this section. 
Exogenous surfaetant administration. The surfactant 
preparation used in these experiments was a lipid extract 
surfactant (bLES Biochemicals Inc., London, Ontario) 
supplied at a concentration of 25 mg phospholipids per 
milliliter. This surfactant preparation has been used in 
multicenter clinical trials involving neonates with respira- 
tory distress syndrome 16 and has been investigated in 
transplantation 9 and nontransplantation 17 lung injury 
models in animals. 
Radiolabeled exogenous urfactant was prepared as 
follows. Initially, 0.2 ml bLES was extracted into CHC13 
according to the method of Bligh and DyerJ s The upper 
aqueous phase was discarded and to the lower chloroform 
phase was added 10 ffCi 1,2-dipalmitoyl-L-3 phosphatidyl 
[N-methyl-3H] choline (40 to 85 mCi/mmol, Amersham, 
Life Science, Oakville, Ontario). The mixture was then 
dried under a stream of nitrogen. Next, 0.5 ml 0.9% NaCI 
and a few glass beads were added to the dried material 
and the tube was capped and vortexed at maximum speed 
for 5 minutes. The resuspended surfactant was then 
removed and was added to a tube containing the bulk of 
the bLES. This tube was inverted several times to obtain 
uniform mixing of the radioactive material. 
In donor animals that received instilled surfactant, 
[3H]-labeled bLES, 100 mg/kg, was administered via a No. 
16 Foley catheter inserted through a side port of the 
endotracheal tube. Half the dose was given with the 
animal in the right recumbent and the other half in the left 
recumbent position. Each dose was followed by 20 ml of 
room air; the Foley catheter was then removed and 
ventilation was resumed. 
Experimental groups. Animals were randomly assigned 
to one of the following groups: (1) treatment of donor 
animals with instilled bLES immediately after the Onset of 
high-volume ventilation (instilled bLES group), n = 5, 
and (2) no treatment to donor lungs (control group), n = 
5. 
Surfactant aggregate isolation and total protein mea- 
surement. Bronchoscopic lavage fluid specimens from the 
donor lungs before and after high-volume ventilation, 
individual whole lung lavage fluid samples from the donor 
right lung after 17 hours of storage, and samples from the 
transplanted left lungs and native right lungs of recipient 
dogs after 6 hours of reperfusion were analyzed. The 
remaining tissue of the individual obes of the donor, 
transplanted, and native lungs was excised after the lavage 
procedure and homogenized with 0.9% NaC1 in a Waring 
blender. The total volume Of each lobar homogenate was 
recorded and aliquots were extracted in chloroform: 
methanol. 
The brouchoscopic lavage fluid specimens and the 
whole lung lavage fluid specimens were centrifuged at 
150g for 10 minutes at 4 ° C to remove cellular debris. The 
150g supernatant was then centrifuged for 15 minutes at 
40,000 g (4 ° C). The 40,000g pellet was resuspended in
0.9% NaC1 containing calcium chloride, 1.5 mmol/L, and 
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Fig. 1. Po2/F io  2 ratio (mean plus or minus standard error of the mean [SEMI) in the two experimental 
groups during 8 hours of high-volume ventilation in donor animals. Differences between groups, where 
significant, are stated in the text. 
was designated as the LA fraction. 11 The 40,000g super- 
natant was designated as the SA fraction. 9Lipid extracts 
of aliquots of SA and LA were prepared by chloroform: 
methanol extraction according to the method of Bligh and 
Dyer. 18 Total phospholipid content was determined by 
phosphorous analysis of aliquots of the lipid extracts by 
the method of Rouser, Fleischer, and Yamamoto. 19 Total 
protein was quantified in the supernatant of the 40,000g 
centrifugation by a modification of the method of Lowry 
and colleagues, 2°with bovine serum albumin as a stan- 
dard. 
Exogenous surfactant recovery. Extracted aliquots of 
the lavage fluid specimens and lung homogenate samples 
of the instilled bLES group animals were dried under 
nitrogen and [3HI radioactivity was determined by liquid 
scintillation counting. 9' 2i Aliquots of the input radioactive 
surfactant used to treat these donor animals were ex- 
tracted and counted by identical techniques. The total 
recovery of exogenous urfactant was calculated on the 
basis of the total radioactivity present in whole lung lavage 
fluid specimens', and lung tissue analyzed after death 
divided by the total amount of radioactivity administered 
to the donor animals. In addition, the percent radioactiv- 
ity of exogenous bLES in alveolar wash relative to lung 
tissue was calculated. 
Statistical analysis. Results were expressed as means 
plus or minus the standard error of the mean. Statistical 
analysis included a repeated-measures analysis of variance 
assessment, with Dunnett's post hoc tests for sequential 
physiologic variables within each experimental group. In 
addition, unpaired, two-tailed t tests were done on phys- 
iologic variables to compare results between experimental 
groups at each time interval. No adjustment was made for 
multiple testing over time. The changes in neutrophil 
count, prOtein concentrations, and SA/LA ratios in donor 
animal bronchoscopic lavage fluid samples were com- 
pared before and after 8 hours of high-volume ventilation 
by paired, two-tailed t tests. Furthermore, the values of 
SA/LA ratios and total protein in bronchoscopic lavage 
fluid samples and whole lung lavage fluid samples were 
compared between groups by unpaired, two-tailed t tests. 
The SAS statistical software program (Cary, N.C.) was 
used. A p value less than 0.05 was considered significant. 
Results 
Physiologic responses 
High-volume ventilation in donor animals. Before 
the institution of high-volume ventilation, all donor 
animals exhibited normal arterial blood gas values 
and peak inspired pressures (Figs. 1 and 2). The 
mean body weight of the donor dogs was 22.6 _+ 0.8 
kg in the control group and 21.4 + 1.2 kg in the 
instilled bLES group (p = 0.44). The changes in Po 2 
during the 8 hours of high-volume ventilation are 
shown in Fig. 1. In the control group, the Po z value 
significantly decreased over time (p < 0.001). Dun- 
nett's procedure for comparing observations versus 
time 0 showed significant (p < 0.05) decreases in 
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Fig. 2. Changes in values of Pco 2 and peak inspired pressure (PIP) during 8 hours of high-volume 
ventilation in donor animals (mean plus or minus standard error of the mean [SEMI). There were no 
significant differences in Pco 2 and PIP values between groups. 
Po 2 at 60 minutes and 150 to 480 minutes of donor 
ventilation. Animals in the instilled bLES group did 
not exhibit any significant change in Po 2 values 
during the 8 hours of high-volume ventilation (p = 
0.99). The differences in Po2 values between groups 
became significant (p < 0.05) at 120 minutes of 
ventilation and remained significantly different dur- 
ing the next 6 hours of ventilation. Of note, the Po 2 
value at the end of 8 hours of high-volume ventila- 
tion in control animals (337 _+ 27 mm Hg) still 
exceeded the threshold Po2/Fio 2 value of 300 mm 
Hg that is regarded as acceptable by many clinical 
lung transplantation programs. As shown in Fig. 2, 
high-volume ventilation produced an immediate de- 
crease in Pco 2 values and an increase in peak 
inspired pressure values in both groups. From 30 to 
480 minutes of ventilation, Pc% values decreased 
significantly in control animals (p = 0.006) and in 
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Fig. 3. Po2/F io  2 ratio (mean plus or minus standard error of the mean [SEM]) in the two experimental 
groups during reperfusion. Differences between groups, where significant, are stated in the text. Baseline, 
Pretransplantation Poz/Fio z value. 
instilled bLES animals (p < 0.001). Furthermore, 
peak inspired pressure values increased significantly 
from 30 to 480 minutes of ventilation in control dogs 
(p < 0.001), but did not significantly change in 
instilled bLES dogs (p = 0.065). Despite this within- 
group difference in peak inspired pressure, there 
were no significant differences in values of Pco2 or 
peak inspired pressure between control and instilled 
bLES animals at any time during the 8 hours of 
high-volume ventilation. 
Repelfusion in transplant recipients. The mean 
body weight of the recipient dogs was 24.6 _+ 0.5 kg 
in the control group and 26.1 _+ 1.6 kg in the instilled 
bEES group (p = 0.41). All lung transplant opera- 
tions were performed by the same surgeon and the 
warm ischemic times were 50 + 2 minutes and 49 _+ 
3 minutes in control and instilled bLES animals, 
respectively (p = 0.84). The cold storage times were 
16.7 + 0.3 hours in the control and 16.5 _+ 0.1 hours 
in the instilled bLES dogs (p = 0.54). The total 
ischemic times, therefore, were 17.5 _+ 0.2 hours in 
the control group and 17.3 _+ 0.1 hours in the 
instilled bLES group (p = 0.40). Before left pneu- 
monectomy and left lung transplantation, the left 
PA blood flow rate was 412 _+ 67 ml/min in control 
dogs versus 388 +_ 25 ml/min in instilled bLES 
animals (p = 0.76). Immediately after transplanta- 
tion, the left PA blood flow rate was 180 + 26 
ml/min and 180 _+ 61 ml/min in control and instilled 
bLES dogs, respectively. There were no significant 
differences between groups in right or left PA blood 
flow rate at any time during reperfusion. At the end 
of reperfusion, the left PA blood flow rate was 
372 _+ 83 ml/min in control dogs versus 364 _+ 52 
mt/min in instilled bLES animals (p = 0.94). 
Fig. 3 shows the mean Po2/Fio 2 values for the two 
experimental groups during the 6-hour reperfusion 
period after transplantation. Baseline preoperative 
Po2/Fio 2 values were similar in the two groups (p = 
0.54). In the control group, the PoJFio2 value was 
significantly decreased at the onset of reperfusion as 
compared with the baseline preoperative value (p = 
0.001) and the Po2/Fio2 value at the end of donor 
lung ventilation (p = 0.01). During reperfusion, 
there was a further significant decrease in Po2/Fio 2 
values in control animals compared with the initial 
posttransplant value (time 0) (p = 0.003). Dunnett's 
procedure for comparing observations versus time 0 
showed significant (p < 0.05) decreases in Po2/Fio 2 
values at 90 to 210 minutes and at 300 and 360 
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Fig. 4. Changes in values of Pco2 and peak inspired pressure (PIP) during reperfusion (mean plus or 
minus standard error of the mean [SEM]). Differences between groups, where significant, are stated in the 
text. Baseline, Pretransplantation Pco2 and peak inspired pressure values. 
minutes of reperfusion in this group. In instilled 
bLES group animals, the Po2/Fio 2 value immedi- 
ately after transplantation was also significantly less 
than the baseline preoperative value (p = 0.004) and 
the PoJFio 2 value at the end of donor lung ventila- 
tion (p = 0.004). However, there were no further 
significant changes in Po2/Fio 2 values in the instilled 
bLES group dogs during the 6 hours of reperfusion 
(p = 0.91). Differences in Po2/Fio 2 values between 
groups reached significance at 60 minutes (p = 
0.004) and remained significantly different for the 
remainder of the reperfusion interval (p < 0.01). A 
final assessment of oxygenation i the transplanted 
lung in each group was performed after 360 minutes 
of reperfusion by the right PA snaring technique. 
The isolated left lung PoJFio2 value was 54 +_ 26 
mm Hg in control animals versus 225 +_ 49 mm Hg 
in instilled bLES animals (p = 0.02). 
The efficiency of ventilation during reperfusion, 
as assessed by mean Pco2 and peak inspired pres- 
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sure values, is shown in Fig. 4. There were no 
significant changes in Pco 2 values during reperfu- 
sion in either the control group (p = 0.09) or the 
instilled bLES group (p = 0.86) compared with the 
initial postreperfusion value (time 0). By 360 min- 
utes of reperfusion the Pco2 was 47.8 +_ 1.4 mm Hg 
in control animals versus 38.2 _+ 4.1 mm Hg in 
instilled bLES animals (p = 0.058). Peak inspired 
pressure values increased significantly in the control 
group during reperfusion (p < 0.001) as compared 
with the initial postreperfusion value. Dunnett's 
procedure for comparing observations versus time 
0 showed significant (p < 0.05) increases in peak 
inspired pressure values at 180 to 360 minutes of 
reperfusion in this group. In instilled bLES ani- 
mals, peak :inspired pressure values increased 
during reperfusion (p = 0.01), but Dunnett's 
procedure showed significant (p < 0.05) increases 
in this variable only at 330 and 360 minutes 
compared with time 0. Comparison of peak in- 
spired pressure between groups showed signifi- 
cantly (p < 0.05) lower values in instilled bLES 
versus control animals from 90 to 360 minutes of 
rcperfusion. 
Lung lavage fluid analyses 
Bronchoscopic lavage fluid analysis. Broncho- 
scopic lavage fluid neutrophil count, protein concen- 
tration, and SA/LA ratio before and after 8 hours of 
high-volume ventilation are shown in Table I. There 
were no significant differences in these variables 
between groups before the onset of high-volume 
ventilation (time 0). In the control group, 8 hours of 
high-volume ventilation produced significant in- 
creases in lavage fluid neutrophil count (p = 0.05), 
protein concentration (p = 0.002), and ratio of the 
poorly functioning SA to the superiorly functioning 
EA (p = 0.02) compared with the initial values. In 
the instilled bLES group, the lavage fluid neutrophil 
count was highly variable after 8 hours of high- 
volume ventilation and the increase in neutrophil 
count was not significant compared with the initial 
lavage fluid neutrophil concentration (p = 0.30). 
Furthermore, there were no significant increases in 
lavage fluid protein concentration (p = 0.11) after 8 
hours of high-volume ventilation in the instilled 
bLES group. Comparison of bronchoscopic lavage 
fluid results between groups after high-volume ven- 
tilation revealed atrend toward lower protein values 
in the instilled bLES group versus those in the 
control group (p = 0.10). The surfactant SA/LA 
ratio was lower in the instilled bLES group, reflect- 
ing the fact that approximately 95% of the surfac- 
Table I. Changes in bronchoscopic lavage fluid 
neutrophil count, protein concentration, and 
surfactant SA/LA ratios during high-volume 
ventilation 
Neutrophil 
Experimental Time count Protein SA/LA 
group (hr) (× 106/L) (mg/ml) ratio 
Control 0 43 +_ 39 0.44 + 0.16 0.86 -+ 0.15 
8 1387 -+ 502 2.42_+ 0.26 2.36_+ 0.41 
Instilled bLES 0 11 -+ 6 0.20 _+ 0.09 0.66 -+ 0.36 
8 665 _+ 554 1.32_+ 0.55 0.91 _+ 0.22 
See text for p values. 
tant lipid in bLES was in the surface-active LA form 
before instillation. 
Whole lung lavage fluid analysis. The ratios of 
SA/LA in whole lung lavage fluid samples from 
(nonreperfused) onor right lungs, from native right 
lungs, and from transplanted left lung grafts of 
recipient animals after 6 hours of reperfusion are 
shown in Fig. 5. The SA/LA ratio in the donor right 
lungs of the instilled bLES group after 8 hours of 
high-volume ventilation and 17 hours of hypother- 
mic storage was significantly lower than that in the 
control group (p = 0.003). After 6 hours of reper- 
fusion, the SA/LA ratio in the native right lung of 
recipient animals was lower in instilled bLES ani- 
mals than that in control animals (p = 0.05). The 
SA/LA ratio was also significantly lower in the 
instilled bLES group, as compared with that in the 
control group, in transplanted lungs that had under- 
gone 6 hours of reperfusion (p = 0.009). There were 
no significant differences between the control and 
instilled bLES groups in total protein recovered 
from nonreperfused donor lungs (p = 0.22) and 
from the native right lungs (p = 0.44) and trans- 
planted left lungs (p = 0.50) of recipient animals 
(data not shown). 
Recovery of exogenous urfactant. The total re- 
covery of the instilled exogenous bLES, on the basis 
of the calculated [3H] label recovery in whole lung 
lavage fluid and tissue from donor, native, and 
transplanted lungs, was 64.3% _+ 1.5% (64.3 mg 
phospholipid per kilogram body weight) in the in- 
stilled bLES group. Of the recovered exogenous 
surfactant, 47.1% _+ 2.1% was isolated from the 
nonreperfused onor right lung, 43.4% +_ 2.5% 
from the transplanted left lung, and 9.5% _+ 3.1% 
from the native right lung of the recipient animals. 
In the donor lungs, 60% _+ 10.8% of the total 
recovered bLES was obtained from the alveolar 
350 Novick et aL 
The Journal of Thoracic and 
Cardiovascular Surgery 
February 1997 
_o 
<h 
J 
o9 
SURFACTANT AGGREGATE FORMS 
2.0 
1.0 
T 
o 
DONOR LUNGS N ATIV 
I [ ]  CONTROL 
[ ]  bLES TREATED 
{ -+ SEM 
T 
l i 
LUNGS TRANSPLANTED LUNGS 
Fig. 5. The ratio of surfactant small aggregates to large aggregates in stored donor right lungs, in the 
native right lungs of recipient animals, and in transplanted left lung grafts after 6 hours of reperfusion. 
Differences between groups, where significant, are stated in the text. SEM, Standard error of the mean. 
wash, relative to lung tissue. The percentage of 
radiolabeled bLES in the alveolar wash was 41.9% 
_+ 5% in transplanted left lung grafts and 47.3% _+ 
9.1% in the native right lungs of recipient animals. 
There were no significant differences in the percent 
recovery of radiolabeled bLES from the alveolar 
wash in donor, native, and transplanted lungs (p = 
0.36). 
Discussion 
During the past decade lung transplantation has 
evolved into a successful therapy for selected pa- 
tients with end-stage respiratory and cardiorespira- 
tory failure. Nonetheless, the shortage of suitable 
donor lungs remains a major limiting factor in 
pulmonary transplantation a d accounts for the fact 
that since 1993 only approximately 1000 lung trans- 
plantations have been performed yearly by more 
than 110 clinical lung transplantation programs. 2 
Laboratory studies have suggested that prevention 
of pulmonary endothelial cell damage and dysfunc- 
tion of the alveolar type II cells that produce 
pulmonary surfactant is critical to the successful 
long-term preservation of lung grafts. 1Recent work 
in a rat lung transplant model showed that exoge- 
nous surfactant administered before reperfusion 
improved immediate posttransplantation lu g func- 
tion. 22 In dogs, however, the improvement in oxy- 
genation during reperfusion by surfactant adminis- 
tration after 38 hours of ischemia was only modest, 23 
suggesting that earlier administration of exogenous 
surfactant may be superior. Indeed, subsequent 
experiments in our laboratory have demonstrated 
satisfactory 36-hour preservation of normal canine 
lung grafts that received exogenous bLES before 
hypothermic storage of the graft. 9 The results of 
these animal studies suggested that administration 
of exogenous surfactant to potential donors should 
be tested in clinical trials. In the clinical setting, 
however, most donor lungs are unsuitable for trans- 
plantation because of edema, aspiration, infection, 
ventilator-induced injury, or lung contusion. 3'4 If 
the dysfunction of some of these grafts could be 
significantly reduced or even prevented by adminis- 
tration of exogenous surfactant to these lungs before 
procurement, a significant expansion of the pool of 
donor lungs would be possible. 
A model of ventilation-induced lung injury was 
used in this study for several reasons. First, pilot 
studies in our laboratory demonstrated that me- 
chanical ventilation of donor animal lungs for 8 
hours with a tidal volume of 45 ml/kg predictably 
produced significant increases in bronchoscopic la- 
vage fluid protein concentration and neutrophil 
counts, as well as moderate decreases in Po2/Fio 2 
values over this time. Despite this deterioration i  
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lung function, these Po2/Fio 2 values still exceeded 
the threshold value of 300 mm Hg that is regarded 
as acceptable by many clinical lung transplantation 
programs. Second, transplantation of these grafts 
after 16 to 17 hours of hypothermic storage repro- 
ducibly resulted in poor gas exchange during reper- 
fusion, thereby representing a suitable control group 
for these studies. Third, the model of ventilation- 
induced lung injury has been studied extensively, 
albeit in a nontransplantation setting, by numerous 
other investigators. 11-14 Recent studies have also 
demonstrated that ventilation of rabbit lungs at a 
tidal volume of 13 to 15 ml/kg, as compared with 8 
to 10 ml/kg, is associated with abnormal surfactant 
metabolism; specifically an increase in the conver- 
sion of the surface-active LA forms to the inactive 
SA forms in the air space, is In the clinical setting, 
many lung donors with no evidence of aspiration, 
pulmonary edema, lung contusion, or infection have 
a markedly increased intrapulmonary shunt, l' 24 pos- 
sibly as a result of lung injury caused by mechanical 
ventilation. Moreover, a significant number of po- 
tential donor lungs that are suitable for procure- 
ment and subsequent transplantation are from a 
patient population that has received mechanical 
ventilation for prolonged periods. Our model of 
ventilation-induced lung injury is therefore clinically 
relevant to efforts to expand the pool of donor lungs 
and minimize posttransplantation pulmonary dys- 
function. 
In this study, the bronchoscopic lavage fluid neu- 
trophil count increased markedly in the control 
group after 8 hours of mechanical ventilation, con- 
sistent with increased neutrophil infiltration of the 
lung grafts. The control and instilled bLES animals 
received ventilation in an identical manner and 
there were no significant differences between groups 
in Pc02 and peak inspired pressure values before 
lung procurement. Nevertheless, in control animals 
there were significant increases in lavage fluid pro- 
tein concentration and the ratio of the poorly func- 
tioning SA to superiorly functioning LA after 8 
hours of mechanical ventilation. Serum proteins 
have been shown to inhibit surfactant function both 
in vitro and in vivo. 25' 26 Moreover, previous tudies 
have demonstrated that an increased concentration 
of surfactant SA relative to LA was associated with 
lung injury in transplantation 6' 9 and nontransplan- 
tation 8, 27, 28 animal models, as well as in patients 
with acute respiratory distress yndrome. 29 Recent 
work has also revealed that exogenous surfactant is
capable of mitigating the inflammatory response in 
vitro, 3° although to our knowledge this has not yet 
been shown in vivo. In the current study, exogenous 
surfactant administration at the onset of ventilation 
decreased protein leak and resulted in more of the 
alveolar surfactant in the surface-active LA form. 
This in turn protected the lung from the adverse 
effects of positive pressure ventilation and pre- 
vented the deterioration of Po2 values in donor 
animals. The physiologic differences between the 
control and instilled bLES groups at the end of 8 
hours of ventilation suggested that the latter group 
of lung grafts would be better able to tolerate a 
subsequent prolonged interval of hypothermic stor- 
age. Indeed, reperfusion of these lung grafts after 
transplantation resulted in superior Po 2 values and 
improved ventilation efficiency in the instilled bLES 
group as compared with these values in animals 
given donor lungs that did not receive exogenous 
surfactant. 
Interestingly, whole lung lavage fluid samples 
after 6 hours of reperfusion demonstrated that most 
of the exogenous surfactant remained in the surface- 
active LA form (Fig. 5), even though the treated 
grafts had received only a single dose of bLES 32 
hours earlier. This may reflect the relatively large 
dose of instilled bLES that was administered to 
donor animals (100 mg/kg) and the fact that approx- 
imately 95% of the surfactant lipid in bLES was in 
the LA form before instillation. Alternatively, the 
LA forms in bLES may have been less susceptible to 
conversion to the inactive SA forms after transplan- 
tation. The surfactant recovery data demonstrated 
that 43.4% _+ 2.5% of the [3H]-labeled bLES ad- 
ministered into the trachea of donor animals was 
present in transplanted left lung grafts during reper- 
fusion, whereas only 9.5% _+ 3.1% had spilled over 
into the recipient's native right lung. Previous tud- 
ies in lung transplantation models in rats 22 and 
dogs 23 have shown that exogenous surfactant admin- 
istered after prolonged graft storage can reduce lung 
injury during reperfusion, although earlier surfac- 
tant treatment of lung donors is more effective. 9 The 
beneficial effects of bLES in the current study were 
thus not only a result of its ability to mitigate 
ventilation-induced injury in lung donors, but also of 
its ability to decrease lung injury during the critical 
early hours after transplantation. 
Although the physiologic manifestations of lung 
injury caused by the combined effects of mechanical 
ventilation, lung graft storage, and transplantation 
were significantly reduced by donor bLES treat- 
ment, further studies need to be done to determine 
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the extent o which exogenous bLES therapy can 
decrease histologic, morphometric, and ultrastruc- 
tural pulmonary parenchymal damage in this model. 
In addition, other types of lung injury that are 
prevalent in multiorgan donors, such as edema, 
pulmonary infection, aspiration, and lung contusion, 
should be characterized in experimental lung trans- 
plantation models; the ability of exogenous surfac- 
tant therapy to salvage these lungs so that they may 
successfully be used for transplantation should be 
investigated. Because in the clinical setting most 
donor lungs exhibit significant dysfunction, a clinical 
trial to examine the safety and efficacy of exogenous 
surfactant therapy in potential donors should be 
undertaken. Moreover, innovative techniques to im- 
prove pulmonary endothelial cell function during 
donor lung injury, graft storage, and reperfusion 
must also be developed, since as a combination of 
treatment modalities will likely prove necessary to 
increase the number of lung grafts available for 
transplantation a d to minimize posttransplant pul- 
monary dysfunction. 
We acknowledge the assistance of Heather L. Motloch 
in manuscript preparation. Larry W. Stitt, MSc, provided 
expert advice in techniques of statistical analysis. The 
bLES was supplied by bLES Biochemicals Incorporated, 
London, Ontario, Canada. 
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Discuss ion  
Dr. Keith S. Naunheim (St. Louis, Mo.). I would like to 
know what percentage of the donor pool the authors think 
might be salvageable with this strategy. Certainly ventila- 
tor-induced injury is but one of a myriad of problems that 
can occur that will prevent harvesting of the lung. Do the 
authors think this is going to have a significant clinical 
impact? 
Dr. Gehman. That is difficult o know. These studies are 
preliminary, but they do indicate that at least in this model 
of lung injury there is some potential to salvage some lost 
lung grafts. 
Dr. Naunheim. One of the problems with surfactant 
therapy, especially in the adult, has to do with significant 
cost. Can the authors tell us what it might cost to salvage 
a lung harvest? I know that there are some pulmonologists 
who believe that surfactant therapy is prohibitive in terms 
of cost and certainly in the adult setting. 
Dr. Gehman. That is true. The use of bLES in the 
neonatal population iscostly, and there is no question that 
similar therapy in adult donors would also be costly, since 
it would require larger volumes of bLES to treat donors. 
There is no question, however, that the cost will decrease 
with time. 
Dr. Thomas M. Egan (Chapel Hill, N.C.). How would 
the authors anticipate using this in a clinical setting to 
expand the donor pool and to differentiate those lungs 
that are dysfunctional because of some kind of acute 
respiratory distress yndrome from those that are dysfunc- 
tional because of the high incidence of aspiration and 
infection in brain-dead onors? 
Dr. Gehman. At this time our work is centered on only 
one mechanism of lung injury. I would anticipate that if 
there was a patient who was receiving ventilator support 
for a prolonged period who had clear findings on the chest 
x-ray film, that would be the patient who would be 
considered for surfactant therapy. 
Dr. Larry R. Kaiser (Philadelphia, Pa.). Am I correct in 
assuming that in this model the surfactant was given 
before the induction of the high tidal volume ventilation? 
Dr. Gehman. We gave the surfactant simultaneously 
with the onset of high-volume ventilation. There is evi- 
dence in the literature that even ventilation at normal 
tidal volumes leads to significant alterations in the SA/LA 
ratio and impairments in the surfactant system. We have 
also conducted preliminary experiments hat administered 
surfactant 3 hours after the institution of high-volume 
ventilation. After reperfusion in the recipient here was a 
return of oxygenation values to numbers imilar to those 
seen in surfactant-treated donors who received surfactant 
at the onset of high-volume ventilation. 
Dr. Kaiser. Therefore you have applied this treatment 
to an injury that has already begun and have been able to 
show some reversal. 
